RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE
Main Authors: | Seeman, E, Chapurlat, R, Cheung, A, Felsenberg, D, La-Roche, M, Reeve, J, Thomas, T, Zanchetta, J, Bock, O, Morris, E, Tile, L, D'Alo, G, Darbie, L, Borah, B, Rizzoli, R |
---|---|
Format: | Journal article |
Published: |
2010
|
Similar Items
-
Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
by: Bala, Y, et al.
Published: (2014) -
Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.
by: Sugiyama, T, et al.
Published: (2011) -
Risedronate or exercise for lean mass preservation during menopause: secondary analysis of a randomized controlled trial
by: Laura E. Flores, et al.
Published: (2022-07-01) -
Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.
by: Seeman, A, et al.
Published: (2000) -
Spontaneous Incomplete transverse subtrochanteric femoral fracture with cortical thickening possibly secondary to risedronate use: a case report
by: Alfahad Anas, et al.
Published: (2012-09-01)